「the 20」の検索結果
144件：81～85件目を表示
-
OTC Products, etc. | Products | SENJU Pharmaceutical
Inquiries are not accepted in a language other than Japanese in principle. Please kindly understand the situation that the inquiries by telephone must use Japanese only. Translated from the Japanese p...
http://www.senju.co.jp/english/products/otc.html -
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
o-Controlled Phase 3 Pivotal Study – Yuichi Hori, MD, PhD; Tomoyuki Wada, PhD; Kazunori Omatsu, BSc the 59th Congress of the European Societies of Toxicology 開催日：2025年9月14日～2025年9月17日 開催地：Athens, GREE...
http://www.senju.co.jp/english/rd/society/ -
tical Co., Ltd. Senju announces initiation of Phase III Clinical Trials in Japan for “SJP-0008” for the treatment of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. (Headquarters: Osak...
https://www.senju.co.jp/system/files/content_news/2024-05/ENG_20240509_0.pdf -
Quality Policies | About Senju | SENJU Pharmaceutical
We will set the following "Quality Policies" and continue to be a "Good Company" by encouraging cooperation among all employees and providing high-quality products for "realiz...
https://www.senju.co.jp/english/about/quality.html -
da Pharmaceutical Co., Ltd. Senju has Applied for Manufacturing and Marketing Approval in Japan for the novel Dry Eye Disease treatment, SJP-0132 Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, J...
https://www.senju.co.jp/system/files/content_news/2025-01/ENG_20250117_0.pdf